Young-Suk Lim Selected Research

entecavir

1/2022	Methodological challenges of performing meta-analyses to compare the risk of hepatocellular carcinoma between chronic hepatitis B treatments.
1/2022	Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data.
1/2022	Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B.
11/2021	Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B.
7/2021	Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma.
1/2021	Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B.
1/2021	Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection: A Systematic Review and Meta-analysis.
1/2021	Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection.
1/2021	High level of medication adherence is required to lower mortality in patients with chronic hepatitis B taking entecavir: A nationwide cohort study.
1/2020	Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young-Suk Lim Research Topics

Disease

97	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 06/2008
61	Chronic Hepatitis B 01/2022 - 08/2004
33	Neoplasms (Cancer) 11/2022 - 05/2008
23	Infections 01/2022 - 06/2006
21	Fibrosis (Cirrhosis) 01/2021 - 10/2002
11	Hepatitis B 01/2022 - 06/2006
10	Liver Diseases (Liver Disease) 01/2018 - 10/2005
8	Liver Neoplasms (Liver Cancer) 11/2021 - 11/2013
7	Chronic Hepatitis C 01/2022 - 03/2013
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 06/2011
5	Acute Liver Failure (Fulminant Hepatic Failure) 01/2018 - 01/2010
5	Non-alcoholic Fatty Liver Disease 08/2016 - 05/2010
5	End Stage Liver Disease 08/2015 - 10/2005
5	Thrombosis (Thrombus) 03/2015 - 09/2010
3	Hepatitis 01/2022 - 06/2006
3	Cholangiocarcinoma 01/2021 - 01/2018
3	Ascites 01/2020 - 10/2002
3	Hepatic Encephalopathy 01/2020 - 03/2008
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 11/2016
3	Nasopharyngitis 01/2020 - 11/2016
3	Neoplasm Metastasis (Metastasis) 12/2019 - 03/2010
2	Esophageal and Gastric Varices (Esophageal Varices) 01/2022 - 01/2012
2	Fatty Liver 01/2020 - 08/2016
2	Autoimmune Hepatitis 01/2019 - 01/2008
2	Hepatitis E 10/2018 - 09/2011
2	Hepatitis A (Hepatitis, Infectious) 01/2018 - 12/2012
2	Headache (Headaches) 11/2016 - 11/2016
2	Necrosis 11/2015 - 03/2013
1	Atrial Fibrillation 01/2022
1	Coinfection 01/2022
1	Varicose Veins (Varicose Vein) 01/2022
1	Hemorrhage 01/2022
1	Diabetes Mellitus 01/2022
1	Body Weight (Weight, Body) 01/2022

Drug/Important Bio-Agent (IBA)

30	entecavir FDA Link 01/2022 - 10/2009
26	Tenofovir (Viread)FDA Link 01/2022 - 01/2016
20	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2004
18	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2011
14	Alanine Transaminase (SGPT)IBA 11/2022 - 05/2010
12	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2022 - 06/2006
12	Hepatitis B e AntigensIBA 01/2022 - 08/2004
12	Lamivudine (Epivir)FDA Link 11/2019 - 08/2004
10	Sorafenib (BAY 43-9006)FDA Link 04/2021 - 11/2011
10	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 03/2010
9	adefovirIBA 01/2019 - 06/2006
8	gadolinium ethoxybenzyl DTPA FDA Link 01/2022 - 04/2015
8	tenofovir alafenamideIBA 01/2022 - 11/2016
7	Pharmaceutical PreparationsIBA 01/2022 - 07/2013
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
5	Fetal Proteins (Fetoprotein)IBA 01/2022 - 07/2012
4	Ribavirin (Virazole)FDA LinkGeneric 11/2016 - 06/2010
4	CreatinineIBA 11/2016 - 04/2010
3	CholesterolIBA 01/2022 - 08/2012
3	Serum AlbuminIBA 10/2021 - 05/2015
3	NucleosidesIBA 08/2014 - 09/2011
3	hepatitis B hyperimmune globulinIBA 04/2011 - 06/2006
3	Immunoglobulins (Immunoglobulin)IBA 04/2011 - 06/2006
3	adefovir dipivoxil (Hepsera)FDA Link 06/2006 - 08/2004
2	Iodized OilIBA 02/2022 - 03/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 11/2021
2	HDL CholesterolIBA 01/2022 - 01/2012
2	InterferonsIBA 12/2021 - 01/2018
2	NivolumabIBA 07/2020 - 07/2020
2	Gemcitabine FDA Link 11/2018 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 01/2018
2	AntigensIBA 10/2018 - 09/2011
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2017 - 11/2012
2	Interferon-alpha (Interferon Alfa)IBA 11/2016 - 08/2004
2	ORALIT (ORS)IBA 11/2015 - 10/2015
2	Ethiodized Oil (Ethiodol)FDA Link 06/2013 - 03/2013
2	Immunoglobulin M (IgM)IBA 12/2012 - 06/2006
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 02/2011
1	RNA (Ribonucleic Acid)IBA 11/2022
1	AsparagineIBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	cabozantinibIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	fucose-binding lectinIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	nasIBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	VaccinesIBA 12/2021
1	Tumor Biomarkers (Tumor Markers)IBA 11/2021
1	glecaprevir and pibrentasvirIBA 11/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021

Therapy/Procedure

41	Therapeutics 11/2021 - 08/2004
24	Liver Transplantation 01/2022 - 03/2008
15	Radiotherapy 04/2022 - 05/2009
6	Transplantation 01/2021 - 06/2011
5	Radiofrequency Ablation 07/2021 - 12/2013
5	Hepatectomy 01/2021 - 03/2010
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
3	Salvage Therapy 02/2022 - 01/2012
3	Immunotherapy 01/2022 - 06/2015
3	Conformal Radiotherapy 01/2015 - 09/2010
2	Aftercare (After-Treatment) 01/2015 - 06/2008
1	Continuity of Patient Care 11/2021